Diabetic nephropathy.
Shlipak
Michael
M
Epidemiology & Biostatistics, San Francisco VA Medical Center, San Francisco, USA.
D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use; D001713:Biphenyl Compounds / Q000627:therapeutic use; D001786:Blood Glucose / Q000378:metabolism; D002216:Captopril / Q000627:therapeutic use; D003928:Diabetic Nephropathies / Q000188:drug therapy* / Q000628:therapy; D006801:Humans; D000077405:Irbesartan; D019808:Losartan / Q000627:therapeutic use; D013777:Tetrazoles / Q000627:therapeutic use
D000806:Angiotensin-Converting Enzyme Inhibitors; D001713:Biphenyl Compounds; D001786:Blood Glucose; D013777:Tetrazoles; D002216:Captopril; D000077405:Irbesartan; D019808:Losartan